Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection

Overview of attention for article published in Frontiers in Surgery, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 1 X user

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 1 X post from an account with 1,025 followers.

New Research: Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection: Background For breast cancer (BC) with sentinel lymph node micrometastases (SLNMs), there are limited data to guide the… https://t.co

17 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.